Search Results - "Yoritomo, N"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation

    Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation by Chiang, C-H, Su, Y, Wen, Z, Yoritomo, N, Ross, C A, Margolis, R L, Song, H, Ming, G-l

    Published in Molecular psychiatry (01-04-2011)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial

    Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial by Anon

    Published in Lancet neurology (01-01-2015)
    “…Summary Background PBT2 is a metal protein-attenuating compound that might reduce metal-induced aggregation of mutant huntingtin and has prolonged survival in…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Relationship of frontal lobe bold signal and fractional anisotropy in subjects with schizophrenia during a Stroop interference task

    Relationship of frontal lobe bold signal and fractional anisotropy in subjects with schizophrenia during a Stroop interference task by Reading, S, McEntee, J, Tennis, R, Bakker, A, Yoritomo, N, Pekar, J, Mori, S, van Zijl, P, Margolis, RL, Ross, CA

    Published in NeuroImage (Orlando, Fla.) (01-07-2009)
    “…Future directions for these modest findings include larger sample sizes, inclusion of a healthy control group, more complex DTI analysis, and association…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: